MFDS — authorised 26 February 2021
- Marketing authorisation holder: ORIGIN
- Status: likely_approved
🇰🇷 Nulibry in South Korea
MFDS authorised Nulibry on 26 February 2021
Marketing authorisation
Nulibry in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Nulibry approved in South Korea?
Yes. MFDS authorised it on 26 February 2021.
Who is the marketing authorisation holder for Nulibry in South Korea?
ORIGIN holds the South Korean marketing authorisation.